Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,672 | -13,550 | -6,807 | -2,902 | -10,290 |
| Depreciation Amortization | 30 | 1 | N/A | N/A | 0 |
| Accounts payable and accrued liabilities | 18 | -14 | 355 | 22 | N/A |
| Other Working Capital | -102 | -1,093 | -173 | -298 | 380 |
| Other Operating Activity | 3,031 | 2,586 | 182 | 42 | 7,120 |
| Operating Cash Flow | $-17,695 | $-12,070 | $-6,443 | $-3,136 | $-2,790 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -69,066 | N/A | N/A | N/A | N/A |
| PPE Investments | -14 | -14 | -7 | N/A | 0 |
| Investing Cash Flow | $-69,080 | $-14 | $-7 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 74,331 | 74,331 | 159 | 75 | N/A |
| Other Financing Activity | 41,380 | 41,380 | 42,601 | 15,000 | 17,780 |
| Financing Cash Flow | $115,711 | $115,711 | $42,760 | $15,075 | $17,780 |
| Beginning Cash Position | 14,994 | 14,994 | 14,994 | 14,994 | 0 |
| End Cash Position | 43,930 | 118,621 | 51,304 | 26,933 | 14,990 |
| Net Cash Flow | $28,936 | $103,627 | $36,310 | $11,939 | $14,990 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,695 | -12,070 | -6,443 | -3,136 | -2,790 |
| Capital Expenditure | -14 | -14 | -7 | N/A | N/A |
| Free Cash Flow | -17,709 | -12,084 | -6,450 | -3,136 | -2,790 |